Hypertension became the primary contributing cardiovascular cause of death in the US since 2022 marking a shift from acute ischemia to chronic metabolic disease as the dominant CVD mortality driver

Hypertensive disease age-adjusted mortality doubled from 15.8 to 31.9 per 100,000 between 1999-2023. Since 2022, hypertension has become the #1 contributing cardiovascular cause of death in the US, surpassing ischemic heart disease. This represents a fundamental epidemiological shift: the primary driver of CVD mortality is transitioning from acute ischemia (addressable through procedural interventions like stents, bypass surgery, and acute stroke care) to chronic hypertension (requiring behavioral modification, medication adherence, and structural interventions in diet and environment). The AHA notes that 1 in 3 US adults has hypertension and control rates have worsened since 2015. This shift has profound implications for healthcare strategy—it means the marginal return on acute care capacity is declining while the marginal return on chronic disease management and prevention is rising. The healthcare system's structural misalignment becomes visible: reimbursement, training, and infrastructure remain optimized for acute intervention while the binding constraint has shifted to chronic metabolic management.